Keywords
Last Name
Institution

Anthony T Vella PhD

TitleAssociate Professor
InstitutionUConn Health Center
DepartmentImmunology
AddressMC 3710
MC 3710
263 Farmington Avenue
Phone860-679-4364
Fax860-679-8130
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Svedova J, Tsurutani N, Liu W, Khanna KM, Vella AT. TNF and CD28 Signaling Play Unique but Complementary Roles in the Systemic Recruitment of Innate Immune Cells after Staphylococcus aureus Enterotoxin A Inhalation. J Immunol. 2016 Jun 1; 196(11):4510-21. PMID: 27183621.
      View in: PubMed
    2. Ryan JM, Wasser JS, Adler AJ, Vella AT. Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too? Expert Opin Biol Ther. 2016 May; 16(5):655-74. PMID: 26855028.
      View in: PubMed
    3. Tsurutani N, Mittal P, St Rose MC, Ngoi SM, Svedova J, Menoret A, Treadway FB, Laubenbacher R, Suárez-Ramírez JE, Cauley LS, Adler AJ, Vella AT. Costimulation Endows Immunotherapeutic CD8 T Cells with IL-36 Responsiveness during Aerobic Glycolysis. J Immunol. 2016 Jan 1; 196(1):124-34. PMID: 26573834.
      View in: PubMed
    4. Mittal P, St Rose MC, Wang X, Ryan JM, Wasser JS, Vella AT, Adler AJ. Tumor-Unrelated CD4 T Cell Help Augments CD134 plus CD137 Dual Costimulation Tumor Therapy. J Immunol. 2015 Dec 15; 195(12):5816-26. PMID: 26561553; PMCID: PMC4670784 [Available on 12/15/16].
    5. Ménoret A, Svedova J, Behl B, Vella AT. Trace Levels of Staphylococcal Enterotoxin Bioactivity Are Concealed in a Mucosal Niche during Pulmonary Inflammation. PLoS One. 2015; 10(10):e0141548. PMID: 26509442; PMCID: PMC4625020.
    6. Ménoret A, Crocker SJ, Rodriguez A, Rathinam VA, Clark RB, Vella AT. Transition from identity to bioactivity-guided proteomics for biomarker discovery with focus on the PF2D platform. Proteomics Clin Appl. 2016 Jan; 10(1):8-24. PMID: 26201056.
      View in: PubMed
    7. Cauley LS, Vella AT. Why is coinfection with influenza virus and bacteria so difficult to control? Discov Med. 2015 Jan; 19(102):33-40. PMID: 25636959; PMCID: PMC4313126.
    8. Sylvester FA, Draghi A, Menoret A, Fernandez ML, Wang Z, Vella AT. Distinctive colonic mucosal cytokine signature in new-onset, untreated pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2014 Nov; 59(5):553-61. PMID: 25000355.
      View in: PubMed
    9. Montrose DC, Nakanishi M, Murphy RC, Zarini S, McAleer JP, Vella AT, Rosenberg DW. The role of PGE2 in intestinal inflammation and tumorigenesis. Prostaglandins Other Lipid Mediat. 2015 Jan-Mar; 116-117:26-36. PMID: 25460828; PMCID: PMC4385488 [Available on 01/01/16].
    10. Wright KT, Giardina C, Vella AT. Therapeutic targeting of the inflammome. Biochem Pharmacol. 2014 Nov 15; 92(2):184-91. PMID: 25204592.
      View in: PubMed
    11. Adler AJ, Vella AT. Striving for synergy: how to improve cancer immunotherapy through multiple agonist costimulation. Immunotherapy. 2013 Dec; 5(12):1271-3. PMID: 24283834.
      View in: PubMed
    12. Swede H, Hajduk AM, Sharma J, Rawal S, Rasool H, Vella AT, Tobet RE, Stevens RG. Baseline serum C-reactive protein and death from colorectal cancer in the NHANES III cohort. Int J Cancer. 2014 Apr 15; 134(8):1862-70. PMID: 24122448.
      View in: PubMed
    13. Wright KT, Vella AT. RKIP contributes to IFN-? synthesis by CD8+ T cells after serial TCR triggering in systemic inflammatory response syndrome. J Immunol. 2013 Jul 15; 191(2):708-16. PMID: 23761631; PMCID: PMC3702676.
    14. Guglielmetti L, Cazzadori A, Conti M, Boccafoglio F, Vella A, Ortolani R, Concia E. Lymphocyte subpopulations in active tuberculosis: association with disease severity and the QFT-GIT assay. Int J Tuberc Lung Dis. 2013 Jun; 17(6):825-8. PMID: 23676170.
      View in: PubMed
    15. Kumar S, Colpitts SL, Ménoret A, Budelsky AL, Lefrancois L, Vella AT. Rapid aß T-cell responses orchestrate innate immunity in response to Staphylococcal enterotoxin A. Mucosal Immunol. 2013 Sep; 6(5):1006-15. PMID: 23321986; PMCID: PMC3722268.
    16. St Rose MC, Taylor RA, Bandyopadhyay S, Qui HZ, Hagymasi AT, Vella AT, Adler AJ. CD134/CD137 dual costimulation-elicited IFN-? maximizes effector T-cell function but limits Treg expansion. Immunol Cell Biol. 2013 Feb; 91(2):173-83. PMID: 23295363; PMCID: PMC3570742.
    17. Ménoret A, Drew DA, Miyamoto S, Nakanishi M, Vella AT, Rosenberg DW. Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells. Mol Carcinog. 2014 Feb; 53 Suppl 1:E11-22. PMID: 23255428.
      View in: PubMed
    18. Tewalt EF, Cohen JN, Rouhani SJ, Guidi CJ, Qiao H, Fahl SP, Conaway MR, Bender TP, Tung KS, Vella AT, Adler AJ, Chen L, Engelhard VH. Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. Blood. 2012 Dec 6; 120(24):4772-82. PMID: 22993390; PMCID: PMC3520619.
    19. Ménoret A, Kumar S, Vella AT. Cytochrome b5 and cytokeratin 17 are biomarkers in bronchoalveolar fluid signifying onset of acute lung injury. PLoS One. 2012; 7(7):e40184. PMID: 22792238; PMCID: PMC3391234.
    20. Ngoi SM, St Rose MC, Menoret AM, Smith DE, Tovey MG, Adler AJ, Vella AT. Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness. Proc Natl Acad Sci U S A. 2012 Jun 26; 109(26):10486-91. PMID: 22689946; PMCID: PMC3387033.
    21. Kuratnik A, Senapati VE, Verma R, Mellone BG, Vella AT, Giardina C. Acute sensitization of colon cancer cells to inflammatory cytokines by prophase arrest. Biochem Pharmacol. 2012 May 1; 83(9):1217-28. PMID: 22306067; PMCID: PMC3299870.
    22. Ngoi SM, Sylvester FA, Vella AT. The role of microbial byproducts in protection against immunological disorders and the hygiene hypothesis. Discov Med. 2011 Nov; 12(66):405-12. PMID: 22127111.
      View in: PubMed
    23. Qui HZ, Hagymasi AT, Bandyopadhyay S, St Rose MC, Ramanarasimhaiah R, Ménoret A, Mittler RS, Gordon SM, Reiner SL, Vella AT, Adler AJ. CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation. J Immunol. 2011 Oct 1; 187(7):3555-64. PMID: 21880986; PMCID: PMC3178659.
    24. Blair DA, Turner DL, Bose TO, Pham QM, Bouchard KR, Williams KJ, McAleer JP, Cauley LS, Vella AT, Lefrançois L. Duration of antigen availability influences the expansion and memory differentiation of T cells. J Immunol. 2011 Sep 1; 187(5):2310-21. PMID: 21775679; PMCID: PMC3159832.
    25. Nakanishi M, Menoret A, Tanaka T, Miyamoto S, Montrose DC, Vella AT, Rosenberg DW. Selective PGE(2) suppression inhibits colon carcinogenesis and modifies local mucosal immunity. Cancer Prev Res (Phila). 2011 Aug; 4(8):1198-208. PMID: 21576350; PMCID: PMC3151318.
    26. McAleer JP, Saris CJ, Vella AT. The WSX-1 pathway restrains intestinal T-cell immunity. Int Immunol. 2011 Feb; 23(2):129-37. PMID: 21233255; PMCID: PMC3030729.
    27. McAleer JP, Vella AT. Educating CD4 T cells with vaccine adjuvants: lessons from lipopolysaccharide. Trends Immunol. 2010 Nov; 31(11):429-35. PMID: 20880743; PMCID: PMC2967613.
    28. Kumar S, Ménoret A, Ngoi SM, Vella AT. The systemic and pulmonary immune response to staphylococcal enterotoxins. Toxins (Basel). 2010 Jul; 2(7):1898-912. PMID: 22069664; PMCID: PMC3153275.
    29. Khanna KM, Blair DA, Vella AT, McSorley SJ, Datta SK, Lefrançois L. T cell and APC dynamics in situ control the outcome of vaccination. J Immunol. 2010 Jul 1; 185(1):239-52. PMID: 20530268; PMCID: PMC2997353.
    30. Zhang B, Zhang Y, Niu L, Vella AT, Mittler RS. Dendritic cells and Stat3 are essential for CD137-induced CD8 T cell activation-induced cell death. J Immunol. 2010 May 1; 184(9):4770-8. PMID: 20351189.
      View in: PubMed
    31. McAleer JP, Liu B, Li Z, Ngoi SM, Dai J, Oft M, Vella AT. Potent intestinal Th17 priming through peripheral lipopolysaccharide-based immunization. J Leukoc Biol. 2010 Jul; 88(1):21-31. PMID: 20130220; PMCID: PMC2892526.
    32. Ménoret A, McAleer JP, Ngoi SM, Ray S, Eddy NA, Fenteany G, Lee SJ, Rossi RJ, Mukherji B, Allen DL, Chakraborty NG, Vella AT. The oxazolidinone derivative locostatin induces cytokine appeasement. J Immunol. 2009 Dec 1; 183(11):7489-96. PMID: 19917702; PMCID: PMC2799496.
    33. McAleer JP, Rossi RJ, Vella AT. Lipopolysaccharide potentiates effector T cell accumulation into nonlymphoid tissues through TRIF. J Immunol. 2009 May 1; 182(9):5322-30. PMID: 19380779; PMCID: PMC2947744.
    34. Ngoi SM, Tovey MG, Vella AT. Targeting poly(I:C) to the TLR3-independent pathway boosts effector CD8 T cell differentiation through IFN-alpha/beta. J Immunol. 2008 Dec 1; 181(11):7670-80. PMID: 19017955; PMCID: PMC2676428.
    35. Bandyopadhyay S, Long M, Qui HZ, Hagymasi AT, Slaiby AM, Mihalyo MA, Aguila HL, Mittler RS, Vella AT, Adler AJ. Self-antigen prevents CD8 T cell effector differentiation by CD134 and CD137 dual costimulation. J Immunol. 2008 Dec 1; 181(11):7728-37. PMID: 19017962; PMCID: PMC2846364.
    36. Lee SJ, Long M, Adler AJ, Mittler RS, Vella AT. The IKK-neutralizing compound Bay11 kills supereffector CD8 T cells by altering caspase-dependent activation-induced cell death. J Leukoc Biol. 2009 Jan; 85(1):175-85. PMID: 18923104; PMCID: PMC2626763.
    37. Muralimohan G, Rossi RJ, Guernsey LA, Thrall RS, Vella AT. Inhalation of Staphylococcus aureus enterotoxin A induces IFN-gamma and CD8 T cell-dependent airway and interstitial lung pathology in mice. J Immunol. 2008 Sep 1; 181(5):3698-705. PMID: 18714046; PMCID: PMC2576742.
    38. Muralimohan G, Rossi RJ, Vella AT. Recruitment and in situ renewal regulate rapid accumulation of CD11c+ cells in the lung following intranasal superantigen challenge. Int Arch Allergy Immunol. 2008; 147(1):59-73. PMID: 18451649; PMCID: PMC2707756.
    39. McAleer JP, Vella AT. Understanding how lipopolysaccharide impacts CD4 T-cell immunity. Crit Rev Immunol. 2008; 28(4):281-99. PMID: 19166381; PMCID: PMC3549535.
    40. Nakanishi M, Ménoret A, Belinsky GS, Giardina C, Godman CA, Vella AT, Rosenberg DW. Utilizing endoscopic technology to reveal real-time proteomic alterations in response to chemoprevention. Proteomics Clin Appl. 2007 Dec; 1(12):1660-6. PMID: 21136663.
      View in: PubMed
    41. McAleer JP, Zammit DJ, Lefrançois L, Rossi RJ, Vella AT. The lipopolysaccharide adjuvant effect on T cells relies on nonoverlapping contributions from the MyD88 pathway and CD11c+ cells. J Immunol. 2007 Nov 15; 179(10):6524-35. PMID: 17982041.
      View in: PubMed
    42. Salazar-Gonzalez RM, Srinivasan A, Griffin A, Muralimohan G, Ertelt JM, Ravindran R, Vella AT, McSorley SJ. Salmonella flagellin induces bystander activation of splenic dendritic cells and hinders bacterial replication in vivo. J Immunol. 2007 Nov 1; 179(9):6169-75. PMID: 17947692.
      View in: PubMed
    43. Long M, Slaiby AM, Wu S, Hagymasi AT, Mihalyo MA, Bandyopadhyay S, Vella AT, Adler AJ. Histone acetylation at the Ifng promoter in tolerized CD4 cells is associated with increased IFN-gamma expression during subsequent immunization to the same antigen. J Immunol. 2007 Nov 1; 179(9):5669-77. PMID: 17947638; PMCID: PMC2855051.
    44. Carson WF, Guernsey LA, Singh A, Vella AT, Schramm CM, Thrall RS. Accumulation of regulatory T cells in local draining lymph nodes of the lung correlates with spontaneous resolution of chronic asthma in a murine model. Int Arch Allergy Immunol. 2008; 145(3):231-43. PMID: 17914275; PMCID: PMC2576511.
    45. Zhang B, Maris CH, Foell J, Whitmire J, Niu L, Song J, Kwon BS, Vella AT, Ahmed R, Jacob J, Mittler RS. Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent. J Clin Invest. 2007 Oct; 117(10):3029-41. PMID: 17853940; PMCID: PMC1974869.
    46. Müller-Doblies UU, Maxwell SS, Boppana VD, Mihalyo MA, McSorley SJ, Vella AT, Adler AJ, Wikel SK. Feeding by the tick, Ixodes scapularis, causes CD4(+) T cells responding to cognate antigen to develop the capacity to express IL-4. Parasite Immunol. 2007 Oct; 29(10):485-99. PMID: 17883452.
      View in: PubMed
    47. Ramesh M, Turner LF, Yadav R, Rajan TV, Vella AT, Kuhn LT. Effects of the physico-chemical nature of two biomimetic crystals on the innate immune response. Int Immunopharmacol. 2007 Dec 15; 7(13):1617-29. PMID: 17996671.
      View in: PubMed
    48. Lee SJ, Rossi RJ, Lee SK, Croft M, Kwon BS, Mittler RS, Vella AT. CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent. J Immunol. 2007 Aug 15; 179(4):2203-14. PMID: 17675480.
      View in: PubMed
    49. Niu L, Strahotin S, Hewes B, Zhang B, Zhang Y, Archer D, Spencer T, Dillehay D, Kwon B, Chen L, Vella AT, Mittler RS. Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice. J Immunol. 2007 Apr 1; 178(7):4194-213. PMID: 17371976; PMCID: PMC2770095.
    50. Dai J, Liu B, Ngoi SM, Sun S, Vella AT, Li Z. TLR4 hyperresponsiveness via cell surface expression of heat shock protein gp96 potentiates suppressive function of regulatory T cells. J Immunol. 2007 Mar 1; 178(5):3219-25. PMID: 17312170.
      View in: PubMed
    51. Ménoret A, Myers LM, Lee SJ, Mittler RS, Rossi RJ, Vella AT. TGFbeta protein processing and activity through TCR triggering of primary CD8+ T regulatory cells. J Immunol. 2006 Nov 1; 177(9):6091-7. PMID: 17056535.
      View in: PubMed
    52. Cone RE, Li X, Sharafieh R, O'Rourke J, Vella AT. The suppression of delayed-type hypersensitivity by CD8+ regulatory T cells requires interferon-gamma. Immunology. 2007 Jan; 120(1):112-9. PMID: 17052246; PMCID: PMC2265875.
    53. Muralimohan G, Vella AT. A role for IFNgamma in differential superantigen stimulation of conventional versus plasmacytoid DCs. Cell Immunol. 2006 Jul; 242(1):9-22. PMID: 17045255; PMCID: PMC1987380.
    54. Yadav R, Zammit DJ, Lefrancois L, Vella AT. Effects of LPS-mediated bystander activation in the innate immune system. J Leukoc Biol. 2006 Dec; 80(6):1251-61. PMID: 16973890.
      View in: PubMed
    55. Maxwell JR, Yadav R, Rossi RJ, Ruby CE, Weinberg AD, Aguila HL, Vella AT. IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway. J Immunol. 2006 Jul 1; 177(1):234-45. PMID: 16785519.
      View in: PubMed
    56. Salazar-Gonzalez RM, Niess JH, Zammit DJ, Ravindran R, Srinivasan A, Maxwell JR, Stoklasek T, Yadav R, Williams IR, Gu X, McCormick BA, Pazos MA, Vella AT, Lefrancois L, Reinecker HC, McSorley SJ. CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer's patches. Immunity. 2006 May; 24(5):623-32. PMID: 16713979; PMCID: PMC2855652.
    57. Myers L, Lee SW, Rossi RJ, Lefrancois L, Kwon BS, Mittler RS, Croft M, Vella AT. Combined CD137 (4-1BB) and adjuvant therapy generates a developing pool of peptide-specific CD8 memory T cells. Int Immunol. 2006 Feb; 18(2):325-33. PMID: 16373363.
      View in: PubMed
    58. Myers LM, Vella AT. Interfacing T-cell effector and regulatory function through CD137 (4-1BB) co-stimulation. Trends Immunol. 2005 Aug; 26(8):440-6. PMID: 15979409.
      View in: PubMed
    59. Myers L, Croft M, Kwon BS, Mittler RS, Vella AT. Peptide-specific CD8 T regulatory cells use IFN-gamma to elaborate TGF-beta-based suppression. J Immunol. 2005 Jun 15; 174(12):7625-32. PMID: 15944263.
      View in: PubMed
    60. Lee SW, Vella AT, Kwon BS, Croft M. Enhanced CD4 T cell responsiveness in the absence of 4-1BB. J Immunol. 2005 Jun 1; 174(11):6803-8. PMID: 15905521.
      View in: PubMed
    61. Rossi RJ, Muralimohan G, Maxwell JR, Vella AT. Staphylococcal enterotoxins condition cells of the innate immune system for Toll-like receptor 4 stimulation. Int Immunol. 2004 Dec; 16(12):1751-60. PMID: 15504761.
      View in: PubMed
    62. Lee SJ, Myers L, Muralimohan G, Dai J, Qiao Y, Li Z, Mittler RS, Vella AT. 4-1BB and OX40 dual costimulation synergistically stimulate primary specific CD8 T cells for robust effector function. J Immunol. 2004 Sep 1; 173(5):3002-12. PMID: 15322159.
      View in: PubMed
    63. Maxwell JR, Rossi RJ, McSorley SJ, Vella AT. T cell clonal conditioning: a phase occurring early after antigen presentation but before clonal expansion is impacted by Toll-like receptor stimulation. J Immunol. 2004 Jan 1; 172(1):248-59. PMID: 14688332.
      View in: PubMed
    64. Milston RH, Fitzpatrick MS, Vella AT, Clements S, Gundersen D, Feist G, Crippen TL, Leong J, Schreck CB. Short-term exposure of Chinook salmon (Oncoryhnchus tshawytscha) to o,p-DDE or DMSO during early life-history stages causes long-term humoral immunosuppression. Environ Health Perspect. 2003 Oct; 111(13):1601-7. PMID: 14551037; PMCID: PMC1241681.
    65. Milston RH, Vella AT, Crippen TL, Fitzpatrick MS, Leong JA, Schreck CB. In vitro detection of functional humoral immunocompetence in juvenile chinook salmon (Oncorhynchus tshawytscha) using flow cytometry. Fish Shellfish Immunol. 2003 Aug; 15(2):145-58. PMID: 12834618.
      View in: PubMed
    66. Myers L, Takahashi C, Mittler RS, Rossi RJ, Vella AT. Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering. Proc Natl Acad Sci U S A. 2003 Apr 29; 100(9):5348-53. PMID: 12695569; PMCID: PMC154348.
    67. Byrd CM, Bolken TC, Jones KF, Warren TK, Vella AT, McDonald J, King D, Blackwood Z, Hruby DE. Biological consequences of antigen and cytokine co-expression by recombinant Streptococcus gordonii vaccine vectors. Vaccine. 2002 May 22; 20(17-18):2197-205. PMID: 12009273.
      View in: PubMed
    68. Maxwell JR, Ruby C, Kerkvliet NI, Vella AT. Contrasting the roles of costimulation and the natural adjuvant lipopolysaccharide during the induction of T cell immunity. J Immunol. 2002 May 1; 168(9):4372-81. PMID: 11970979.
      View in: PubMed
    69. Weatherill AR, Maxwell JR, Takahashi C, Weinberg AD, Vella AT. OX40 ligation enhances cell cycle turnover of Ag-activated CD4 T cells in vivo. Cell Immunol. 2001 Apr 10; 209(1):63-75. PMID: 11414737.
      View in: PubMed
    70. Takahashi C, Mittler RS, Vella AT. Differential clonal expansion of CD4 and CD8 T cells in response to 4-1BB ligation: contribution of 4-1BB during inflammatory responses. Immunol Lett. 2001 Apr 2; 76(3):183-91. PMID: 11306146.
      View in: PubMed
    71. Prell RA, Dearstyne E, Steppan LG, Vella AT, Kerkvliet NI. CTL hyporesponsiveness induced by 2,3,7, 8-tetrachlorodibenzo-p-dioxin: role of cytokines and apoptosis. Toxicol Appl Pharmacol. 2000 Aug 1; 166(3):214-21. PMID: 10906285.
      View in: PubMed
    72. Vella AT. Uncovering the differences between T cell tolerance and immunity. Arch Immunol Ther Exp (Warsz). 2000; 48(5):331-8. PMID: 11140459.
      View in: PubMed
    73. Maxwell JR, Weinberg A, Prell RA, Vella AT. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion. J Immunol. 2000 Jan 1; 164(1):107-12. PMID: 10605000.
      View in: PubMed
    74. Hamelmann E, Takeda K, Schwarze J, Vella AT, Irvin CG, Gelfand EW. Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytes. Am J Respir Cell Mol Biol. 1999 Oct; 21(4):480-9. PMID: 10502558.
      View in: PubMed
    75. Campbell JD, Cole M, Bunditrutavorn B, Vella AT. Ascorbic acid is a potent inhibitor of various forms of T cell apoptosis. Cell Immunol. 1999 May 25; 194(1):1-5. PMID: 10357874.
      View in: PubMed
    76. Takahashi C, Mittler RS, Vella AT. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J Immunol. 1999 May 1; 162(9):5037-40. PMID: 10227968.
      View in: PubMed
    77. Maxwell JR, Campbell JD, Kim CH, Vella AT. CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion. J Immunol. 1999 Feb 15; 162(4):2024-34. PMID: 9973474.
      View in: PubMed
    78. Weinberg AD, Vella AT, Croft M. OX-40: life beyond the effector T cell stage. Semin Immunol. 1998 Dec; 10(6):471-80. PMID: 9826580.
      View in: PubMed
    79. Lahn M, Kalataradi H, Mittelstadt P, Pflum E, Vollmer M, Cady C, Mukasa A, Vella AT, Ikle D, Harbeck R, O'Brien R, Born W. Early preferential stimulation of gamma delta T cells by TNF-alpha. J Immunol. 1998 Jun 1; 160(11):5221-30. PMID: 9605117.
      View in: PubMed
    80. Vella AT, Dow S, Potter TA, Kappler J, Marrack P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci U S A. 1998 Mar 31; 95(7):3810-5. PMID: 9520449; PMCID: PMC19919.
    81. Teague TK, Marrack P, Kappler JW, Vella AT. IL-6 rescues resting mouse T cells from apoptosis. J Immunol. 1997 Jun 15; 158(12):5791-6. PMID: 9190930.
      View in: PubMed
    82. Vella AT, Mitchell T, Groth B, Linsley PS, Green JM, Thompson CB, Kappler JW, Marrack P. CD28 engagement and proinflammatory cytokines contribute to T cell expansion and long-term survival in vivo. J Immunol. 1997 May 15; 158(10):4714-20. PMID: 9144484.
      View in: PubMed
    83. Hamelmann E, Vella AT, Oshiba A, Kappler JW, Marrack P, Gelfand EW. Allergic airway sensitization induces T cell activation but not airway hyperresponsiveness in B cell-deficient mice. Proc Natl Acad Sci U S A. 1997 Feb 18; 94(4):1350-5. PMID: 9037056; PMCID: PMC19794.
    84. Vella AT, Scherer MT, Schultz L, Kappler JW, Marrack P. B cells are not essential for peripheral T-cell tolerance. Proc Natl Acad Sci U S A. 1996 Jan 23; 93(2):951-5. PMID: 8570666; PMCID: PMC40165.
    85. Vella AT, McCormack JE, Linsley PS, Kappler JW, Marrack P. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity. 1995 Mar; 2(3):261-70. PMID: 7535182.
      View in: PubMed
    86. Humphries D, Vella AT, Pearce EJ. Increased CD4+ T cell-dependent anti-erythrocyte antibody levels following the onset of parasite egg production in Schistosoma mansoni infected mice. Parasite Immunol. 1994 Sep; 16(9):469-77. PMID: 7838596.
      View in: PubMed
    87. Vella AT, Pearce EJ. Schistosoma mansoni egg-primed Th0 and Th2 cells: failure to down-regulate IFN-gamma production following in vitro culture. Scand J Immunol. 1994 Jan; 39(1):12-8. PMID: 7904772.
      View in: PubMed
    88. Vella AT, Pearce EJ. CD4+ T-cell receptor V beta usage during the immune response to Schistosoma mansoni. Infect Immun. 1993 Dec; 61(12):5381-3. PMID: 7901168; PMCID: PMC281325.
    89. Vella AT, Hulsebosch MD, Pearce EJ. Schistosoma mansoni eggs induce antigen-responsive CD44-hi T helper 2 cells and IL-4-secreting CD44-lo cells. Potential for T helper 2 subset differentiation is evident at the precursor level. J Immunol. 1992 Sep 1; 149(5):1714-22. PMID: 1387150.
      View in: PubMed
    90. Vella AT, Pearce EJ. CD4+ Th2 response induced by Schistosoma mansoni eggs develops rapidly, through an early, transient, Th0-like stage. J Immunol. 1992 Apr 1; 148(7):2283-90. PMID: 1347553.
      View in: PubMed
    91. Stellrecht KA, Vella AT. Evidence for polyclonal B cell activation as the mechanism for LCMV-induced autoimmune hemolytic anemia. Immunol Lett. 1992 Feb 15; 31(3):273-7. PMID: 1548040.
      View in: PubMed
    92. Vella AT, Pfau CJ. The presence of an anti-erythrocyte autoantibody in C3HeB/FeJ mice after lymphocytic choriomeningitis virus infection. Autoimmunity. 1991; 9(4):319-29. PMID: 1954312.
      View in: PubMed
    Vella's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _